Rejeunesse Aftercare Guidelines

Key Takeaways

Rejeunesse is a cross-linked hyaluronic acid filler manufactured in South Korea; available in four variants (Fine, Deep, Shape, Sparkle) for superficial to subdermal injection.

A signed consent form is the clinical and legal foundation for safe rejeunesse treatment – it documents informed patient understanding of risks, contraindications, product details, and expected outcomes.

Absolute contraindications include active infection, pregnancy, breastfeeding, and allergy to filler components; relative contraindications require case-by-case clinical judgment and patient discussion.

Pabau’s digital forms and clinical documentation tools help practitioners build compliant, practitioner-specific consent templates and maintain treatment records that meet regulatory standards.

Download your free rejeunesse consent form template

This downloadable template gives you a clinical-grade foundation for documenting informed consent. Customise it with your clinic branding, regulatory jurisdiction, and specific treatment protocols before use.

Rejeunesse filler is a medical-grade hyaluronic acid product administered via injection to correct facial wrinkles, restore volume, and enhance lip contour. Each treatment requires documented informed consent – a written record that the patient understands the treatment purpose, product details, known risks, contraindications, and realistic outcomes.

Without a signed consent form, practitioners face clinical liability, regulatory exposure (CQC audit findings, MHRA documentation requests), and patient disputes over complications or unmet expectations. A robust rejeunesse consent template addresses this gap by anchoring each treatment in a clear, compliant record.

This guide walks you through the essential elements every consent form must contain – product variants, contraindications, side effects, patient declaration language, and signature blocks – plus a downloadable template you can customise for your clinic’s jurisdiction and workflow.

What is a rejeunesse consent form?

A consent form is a written document that confirms a patient has received information about a proposed treatment, understands the risks and benefits, and agrees to proceed. For rejeunesse filler injections, the consent form serves two purposes: clinical documentation of the patient’s informed decision-making, and legal evidence that the practitioner disclosed material risks and obtained permission before injection.

Under UK law (General Medical Council guidance, CQC standards) and US state medical board regulations, practitioners administering aesthetic injectables must obtain documented informed consent. You can verify product approvals via the FDA 510(k) database (US) or the MHRA medicines database (UK). GDPR (UK/EU) and HIPAA (US) further require that patient consent records be stored securely and retained for a minimum period (typically 6-10 years).

The form also protects the patient by providing a clear written record of what was discussed before treatment – helping resolve disputes if complications arise or if the patient’s expectations were not met. This is especially important for rejeunesse, as it is not currently FDA approved in the US market; UK/EU practitioners should note its CE marking and ensure the form accurately reflects the regulatory status in their jurisdiction.

How to use a rejeunesse consent form template

The template provided contains a structured workflow you can follow step by step when administering rejeunesse. Here are the five core steps:

1. Patient identification and treatment history: Collect the patient’s full name, date of birth, contact details, and any previous filler treatments or allergic reactions. This section also asks about current medications (especially anticoagulants or NSAIDs) that may increase bruising risk.
2. Product selection and indication: The practitioner selects which rejeunesse variant will be used (Fine for superficial lines, Deep for wrinkles and volume loss, Shape for contouring, Sparkle for skin hydration). Document the specific treatment areas (nasolabial folds, lips, cheeks, etc.) and the clinical reason for treatment.
3. Contraindication screening: The form lists absolute contraindications (active skin infection, pregnancy, breastfeeding, ingredient allergy) and relative contraindications (immunosuppression, tendency toward keloid formation, unrealistic expectations). The practitioner must confirm the patient has none of these or discuss relative contraindications and document the decision to proceed.
4. Risk and side-effect disclosure: The patient reads and confirms understanding of known risks: injection-site bruising, swelling, tenderness, redness (common, resolve in 1-2 weeks), and rare but serious risks including vascular occlusion, granuloma formation, or allergic reaction. The form must explicitly mention vascular occlusion as a risk to meet informed consent standards.
5. Patient declaration and signature: The patient confirms they have read and understood the form, had the opportunity to ask questions, consent to the treatment, and understand rejeunesse’s regulatory status in their jurisdiction. Both patient and practitioner sign and date the form. A copy goes to the patient; the original is filed in the patient record.

Before first use, have your medical defence organisation (MDU, MPS, MDDUS in UK; malpractice insurer in US) review the template to ensure it meets your jurisdiction’s legal and regulatory standards. Your clinic’s specific policies (aftercare instructions, refund policy, complication reporting) can be appended to the template.

Who is the rejeunesse consent form helpful for?

This template is designed for aesthetic practitioners, dermatologists, and medical spa teams in the UK, US, and EU who administer rejeunesse fillers. Specific practice types include aesthetic clinics offering facial rejuvenation and lip augmentation, dermatology practices incorporating injectable fillers into wrinkle-correction workflows, medical spas and beauty clinics in jurisdictions where qualified nurses or nurse practitioners are permitted to administer rejeunesse under medical supervision, plastic and cosmetic surgery clinics using rejeunesse as a non-surgical or pre/post-operative complement, and private GP clinics offering aesthetic treatments as part of preventive wellness portfolios.

The form is especially valuable for multi-clinician practices where staff turnover or training variations could lead to inconsistent consent documentation. A standardised template ensures every patient receives the same disclosure standard, regardless of which practitioner administers the treatment.

Benefits of using a rejeunesse consent form template

Regulatory compliance: CQC, MHRA (UK), and state medical boards (US) require documented informed consent for injectables. A completed consent form provides auditable evidence you met this standard, reducing regulatory findings and complaints.

Clinical and legal protection: A signed consent form creates a legally contemporaneous record of the patient’s agreement and understanding. If a complication arises or a patient disputes the treatment outcome, the form demonstrates you disclosed material risks and obtained informed permission – a key defence against negligence claims.

Improved patient communication: Standardised consent forms slow the treatment process in the right way – patients have time to read, ask questions, and reflect before signing. This reduces unrealistic expectations, improves satisfaction, and decreases post-treatment complaints.

Workflow consistency: When all practitioners use the same template, contraindication screening, product selection, and risk disclosure are uniform. This protects patient safety and simplifies staff training, compliance audits, and practice-wide policy enforcement.

Documentation clarity for follow-up care: The form records exactly which rejeunesse variant was used and where. This aids future practitioners (or yourself on a recall appointment) in understanding the patient’s treatment history and planning appropriate follow-up or alternative treatments using digital intake forms for consistent record-keeping.

See how Pabau streamlines treatment consent

Build custom consent templates once, use them across all clinicians, and store signed forms securely in one centralised patient record. Pabau’s digital forms and clinical documentation tools make consent workflows effortless.

Book a demo

Rejeunesse product variants and treatment areas

Rejeunesse comes in four cross-linked hyaluronic acid formulations. A complete consent form must specify which variant is being used and document the intended treatment area, as different variants are designed for different injection depths and clinical applications.

Your consent form should prompt the practitioner to circle or select the variant being used. This is critical for post-treatment troubleshooting – if a patient develops unexpected migration or longevity issues, knowing which variant was injected helps diagnose the problem and guides future treatment decisions.

Conclusion

A signed rejeunesse consent form is the foundation of safe, compliant injectable practice. It documents informed patient agreement, protects against regulatory and legal liability, and creates a clear clinical record for future reference. Use the template provided as your starting point – customise it for your clinic’s jurisdiction, policies, and specific patient population – then have your medical defence organisation review it before deployment.

Pabau’s patient communication portal and AI-powered clinical documentation make it easy to build, version-control, and store consent forms securely. Ready to streamline your consent workflow? Book a demo to see how Pabau handles aesthetic treatment documentation.

Continue your research

Need a structured way to document informed consent at scale? Digital intake forms in Pabau let you build once and deploy across your clinic – every patient sees the same consent language, and responses auto-populate your clinical record.

Want to ensure practitioner compliance with consent documentation standards? Skin clinic management software with audit trails and role-based access helps track which staff reviewed consent forms, when, and from which device.

Looking to automate post-treatment communication and complication tracking? Pabau’s automated workflows can trigger follow-up messages, schedule review appointments, and flag high-risk patients for proactive contact within 48 hours of treatment.

Frequently asked questions